Site-specific mutations have been made in the influenza hemagglutinin (HA) receptor binding site to assess the contribution of individual amino acid residues to receptor recognition. Screening of mutant HAs, expressed using recombinant vaccinia virusinfected cells, for their abilities to bind human erythrocytes indicated that substitutions involving conserved residues Y98F, H183F, and L194A severely restricted binding and that the substitution W153A prevented cell surface expression of HA. Mutation of residues E190 and S228 that are in positions to form hydrogen bonds with the 9-OH of sialic acid appeared to increase erythrocyte binding slightly, as did the substitution G225R. Substitutions of other residues that are directly or indirectly involved in receptor binding, S136T, S136A, Y195F, G225D, and L226P, had intermediate effects on binding between these two extremes. Estimates of changes in receptor binding specificity based on inhibition of binding to erythrocytes by nonimmune horse sera indicated that mutants G225R and L226P, unlike wild-type HA, were not inhibited; Y195F and G225D mutants were, like wild type, inhibited; and erythrocyte binding by mutants S136A, S136T, E190A, and S228G was only partially inhibited. Viruses containing mutant HAs Y98F, S136T, G225D, and S228G that cover the range of erythrocyte binding properties observed were also constructed by transfection. All four transfectant viruses replicated in MDCK cells and embryonated hens' eggs as efficiently as wild-type X-31 virus, although the Y98F mutant virus was unable to agglutinate erythrocytes. Mutant MDCK cells that have reduced levels of cell surface sialic acids were susceptible to infection by S136T, G225D, and S228G transfectant viruses and by wild type but not by the Y98F transfectant virus.
INTRODUCTION
Sialic acids of cell surface glycoproteins and glycolipids are receptors for influenza viruses (reviewed in Gottschalk, 1959) ; the virus components that recognize them are the hemagglutinin (HA) glycoproteins of the virus membrane (reviewed in Wiley and Skehel, 1987) . The sites at which the receptors are bound are at the virus membrane distal tip of each subunit of the HA trimer. This region was recognized in the initial X-ray structure analysis of HA (Wilson et al., 1981) as a pocket of conserved residues with the potential, because of its location, to be involved in receptor recognition. Its identity as the receptor binding site was deduced from the molecular locations of variant residues in mutant HAs which displayed different binding properties (Rogers et al., 1983) and this was confirmed by X-ray structures of HA±receptor analogue complexes ( Fig. 1 ; Weis et al., 1988; Sauter et al., 1992; Watowich et al., 1994; Eisen et al., 1997) . These results indicate that conserved residues tryptophan 153, tyrosine 195, histidine 183, and tyrosine 98 interact in a hydrogen-bonded network to form the base of the site; glutamic acid 190 and leucine 194 are generally conserved residues in a short ␣-helix that forms its membrane distal edge; and conserved serine 136 is on its lower edge. Analysis of such HA±receptor analogue complex structures together with studies of receptor analogue binding in solution (Sauter et al., 1989) demonstrate the orientation of bound sialic acid in the site, the interactions it makes with the protein, and the importance for binding of its different substituents. Sialic acid is bound with one side of the pyranose ring facing toward the base of the site. The axial carboxylate, the acetamido nitrogen, and the 8-and 9-hydroxyls face into the site and hydrogen bond with conserved side chain or main chain polar atoms. Thus, conserved serine 136 forms a hydrogen bond with the carboxylate which is also hydrogen bonded to the amide of peptide bond 137; histidine 183 and glutamic acid 190 hydrogen bond with the 9-hydroxyl group and tyrosine 98 with the 8-hydroxyl. The 5-acetamido nitrogen forms a hydrogen bond with the carbonyl of peptide bond 135 and the methyl group of this substituent is in van der Waals contact with the six-membered ring of tryptophan 153. The 7-hydroxyl and acetamido carbonyl hydrogen bond to each other and form van der Waals contacts with leucine 194. By comparison the 4-hydroxyl projects out of the site and appears not to participate in binding.
Differences in receptor recognition specificity that have been reported include distinction between the ␣2,3 and ␣2,6 linkages that terminal sialic acids make with penultimate residues in carbohydrate side chains (Rogers et al., 1983; Connor et al., 1994) . None of the atoms involved in the linkages interacts directly with amino acid residues in the site but substitutions of leucine 226 in particular, on the left edge of the site, have been associated with changes in linkage recognition specificity (Rogers et al., 1983) . The orientations of the carbohydrate side chains as they extend out of the site are determined by these glycosidic linkages and are quite distinct. Pentasaccharides containing the ␣2,3-linked chain exit the site toward the trimeric interface near glutamic acid 190; ␣2,6-linked chains on the other hand, as a result of their folded conformation, exit toward the opposite end of the short membrane distal ␣-helix, near residue 194 (Eisen et al., 1997) . The binding affinities of these pentasaccharides are found to be similar to that of ␣-methylsialic acid (Sauter et al., 1989; Weinhold and Knowles, 1992; Charych et al., 1993) , which is consistent with the observation that in the analogues studied only the terminal sialic acid makes contact with the HA surface.
In the studies reported here we have examined the importance of the contributions of individual residues in the site for binding and specificity. We have specifically substituted all conserved residues in the site and a number on the left edge of the site that have been implicated in binding specificity and we have expressed the mutant HAs in recombinant vaccinia virus-infected cells and in influenza viruses constructed by reverse genetics. Our observations highlight the importance of tryptophan 153 for the structure of HA in this region, demonstrate the special importance for binding of tyrosine 98, histidine 183, and leucine 194, and confirm the cooperative nature of HA±receptor interactions involved in virus infection.
RESULTS
The amino acid substitutions that we have introduced into the sialic acid binding site replace individually the conserved residues W153, Y195, H183, and Y98 that are linked by hydrogen bonds and positioned centrally in the base of the site; S 136, a conserved hydroxyl amino acid on the lower edge of the site; E 190 and L 194, conserved residues that are components of the short ␣-helix forming the virus membrane distal edge of the site; and residues G 225, L 226, and S 228 on the left edge of the site nearest the trimeric interface (Fig. 1) . The mutations involve residues of similar size with different functionality, Y98F, S136A, H183F, Y195F; exchanges for alanine, E190A, L194A, W153A; or substitutions that have occurred in the HAs of previously described natural isolates or laboratory-selected mutants, S136T, G225D, G225R, S228G, and L226P. These substitutions, together with the interactions that the residues make and the degree of their conservation, are listed in Table 1 .
Studies using recombinant vaccinia virus-expressed HA mutants
Surface expression and antigenicity of mutant HAs (a) Accessibility to proteolytic processing. Recombinant vaccinia virus-infected cells express the HA on the cell surface in the uncleaved precursor form, HA 0 . In order to activate the fusion potential of HA, expressing cells are treated with a protease such as trypsin to cleave HA 0 into HA 1 and HA 2 . The accessibility of expressed HA 0 to trypsin provides an assay for cell surface transport. CV1 cell monolayers were infected in parallel with different recombinant vaccinia viruses and cell monolayers expressing wild-type (wt) and mutant HAs were incubated in the presence or the absence of trypsin. Immunoblot analysis of the cell lysates with polyclonal serum against HA revealed that all HAs with the exception of W153A were cleaved into HA 1 and HA 2 (Fig.  2) , indicating that this mutant may not have been transported to the cell surface but that all others were. It is possible that this protein does not fold correctly and is degraded intracellularly.
(b) Antibody recognition. The mutant HAs were also analyzed by ELISA using a panel of five monoclonal antibodies which bind to structurally distinct antigenic regions of wt HA; HC3, HC31, HC68, HC100, and HC263 select for neutralization-resistant mutants with changes at HA 1 residues 146, 198, 193, 63, and 158, respectively (Daniels et al., 1983) . Confluent HeLa cell monolayers were infected with recombinant vaccinia viruses and at 15 h postinfection antibody reactivities with cell surface HAs were determined ( Table 2 ). The experiment was also done using HA-expressing cells either untreated or treated with trypsin to cleave HA 0 into HA 1 and HA 2 and the antibodies reacted equally well with HA 0 and cleaved HAs in each case (not shown). The mutant W153A failed to react with any of the monoclonal antibodies, supporting the evidence from the trypsin cleavage experiments that this mutant HA is not transported to the cell surface. Other mutants, H183F, and Y195F had somewhat lower reactivities to all monoclonal antibodies, suggesting a reduced level of cell surface expression rather than an effect of these mutations on the antigenic structure of any specific region of the molecule. Two examples were observed in which the mutation resulted in loss of antibody reactivity; monoclonal antibody HC68 failed to react with mutants L226P and S136A. This antibody has been shown previously to select neutralization-resistant mutants with a substitution at residue 193 of HA 1 , which is in the short ␣-helix at the membrane distal edge of the receptor binding site, about 15 Å from residues 226 and 136. These residues may, therefore, also be components of the antibody binding site.
(c) Membrane fusion activities of mutant HAs. Following trypsin treatment and incubation at pH 5.0, none of the cell surface-expressed mutants reacted with HC31 and HC68, the two antibodies known to react with the native but not the low-pH conformation of HA. This suggests that all surface-expressed HAs are capable of going through the characteristic acid-induced conformational changes required for membrane fusion activity. The capacities of wild-type and mutant HAs to mediate membrane fusion and the pH at which fusion takes place were assayed by recording polykaryon formation by HAexpressing cells. Following infection with recombinant vaccinia viruses, HA-expressing BHK cell monolayers were trypsin-treated and incubated at the pH indicated (Fig. 3 ). Cells were then neutralized and observed for polykaryon formation by microscopy. All mutants except W153A, which is not expressed on the cell surface, clearly mediate fusion and all had activity at the same pH as wild-type HA, between pH 5.3 and 5.5, with the exception of the mutant L226P, which displayed fusion activity between pH 5.7 and 5.9. The elevated pH of fusion for L226P HA correlates with the elevated pH of fusion reported previously for a double mutant containing this amino acid substitution (Daniels et al., 1987) . No polykaryon formation was observed following low-pH The results of these three different assays of HA expression and function indicate that with the exception of W153A HA the mutants used in this study are expressed on the cell surface, are folded correctly, and are functional with respect to membrane fusion activity.
Receptor binding activity of mutant HAs
The receptor binding activity of mutant HAs was assayed by binding human erythrocytes loaded with horseradish peroxidase (HRP) to HA-expressing HeLa cell monolayers. Recombinant vaccinia virus-infected HeLa cell monolayers expressing the wild-type and mutant HAs were treated with neuraminidase and then with trypsin, to cleave HA 0 into HA 1 and HA 2 , and incubated with HRP-loaded erythrocytes for 40 min at 37°C. Cells were washed several times to remove unbound erythrocytes and binding was quantitated by assaying for the level of HRP activity due to erythrocytes which were still bound. The level of expression of the HAs was assessed in parallel by ELISA. The results for binding activity were corrected for level of HA expression and are presented in Table 3 as percentages of the values obtained for wildtype HA. As negative controls either vaccinia-infected cells not expressing HA or erythrocytes which had been pretreated with neuraminidase to remove receptors for HA were used. Using these controls there was no binding of erythrocytes to vaccinia-infected cell monolayers. For three of the mutants, E190A, G225R, and S228G, binding activity was slightly higher than that of wild-type HA. A number of mutants displayed only partial binding activity and for three of the mutants, Y98F, H183F, and L194A, binding activity was almost completely abolished. Comparative binding studies of wild-type HA, L194A, E190A, and Y98F mutants were also done using surface plasmon resonance assays (Takemoto et al., 1996) . The results were similar to those reported here except that lower binding activity was recorded for mutant E190A (Takemoto, 1997) . We also assayed the mutant HAs for their ability to bind erythrocytes in the presence of horse serum, which functions as a potent binding inhibitor of HAs such as wild-type X-31 HA that recognize sialic acid in ␣2,6 linkage (Pritchett and Paulson, 1989) . The data in Table 4 show that Y195F and G225D HAs were inhibited to the same extent as wild-type HA. The other mutant HAs displayed a range of inhibition, with mutant L226P being the most resistant to inhibition. This is consistent with the observation that growth of X-31 virus in the presence of horse serum selects for mutations at residue 226 (Rogers et al., 1983) . These results indicate that mutants S136A, S136T, E190A, G225R, L226P, and S228G are more resistant than wt HA to inhibition by nonimmune horse sera, and this may reflect their abilities to bind sialic acid in ␣2,3 linkage. To assess the ability of the mutants to recognize sialic acid containing 5-N-glycolyl substituents we also determined their binding activities using horse erythrocytes. Like wild-type X-31, none of the mutants bound these erythrocytes.
Studies using transfectant viruses

Generation of receptor-site mutant transfectant viruses
The above results demonstrate that substitution of conserved residues in the receptor binding site can affect the ability of HA to bind to human erythrocytes. To determine the significance of this binding for virus infectivity, mutant transfectant viruses were generated. cDNAs corresponding to mutant HAs with poor (Y98F), intermediate (S136T and G225D), and strong (S228G) erythrocyte binding activities were subcloned into the reverse genetics vector pT3 X-31, and mutant and wildtype transfectant viruses were constructed as described previously (Enami and Palese, 1991) .
Infectivity of transfectant viruses
All transfectant viruses replicated in MDCK cells and embryonated chicken eggs yielding virus at titers of approximately 10 7 plaque-forming units (PFU)/ml. Assays of the ability of the MDCK-grown viruses to agglutinate human and turkey erythrocytes indicated that all except Y98F were able to efficiently agglutinate erythrocytes from both species (Table 5) . Hemagglutination by Y98F virus was detectable only when more dilute preparations of erythrocytes were used. Similar results were obtained with egg-grown viruses.
Infectivity of transfectant viruses in cells with low sialic acid content
All four receptor-site mutant transfectant viruses including Y98F, which was unable to agglutinate erythrocytes, were able to infect MDCK cells and eggs with efficiencies comparable to those of wild type. One explanation of this observation is that sialic acid-containing receptors are abundant in these two systems (Ito et al., 1997) and allow a sufficient number of HA±sialic acid interactions to occur for effective virus attachment, even for mutant viruses with low binding activity. To examine this possibility a mutant ricin-resistant MDCK cell line (MDCK RCA r ) with reduced levels of sialic acid-containing glycoconjugates on the cell surface, was also used for infectivity studies. These cells have a 70 to 75% reduction in cell surface sialic acid (Bra Èndli et al., 1988) but retain the typical characteristics of polarized epithelial cells and have been reported to support VSV and influenza infections, although virus yields were slightly reduced (Green et al., 1981) . The transfectant viruses were adsorbed in parallel on monolayers of mutant and wild-type MDCK cells and their infectivity was determined by plaque assay (Fig. 4) . Although infectivity and plaque size are slightly reduced for wild type, S228G, and S136T viruses, the effects are much more dramatic with the Y98F virus. Figure 5 shows monolayers of both cell types overlaid with five dilutions of wild-type HA and Y98F virus stocks of approximately equal infectivity titer a Binding of these mutants was too low in the absence of serum to measure a level of inhibition. on wild-type MDCK cells and clearly demonstrates the restriction of infectivity and growth of Y98F virus on the sialic acid-depleted cell line. These results illustrate that infection of cells by influenza viruses, which is assumed to involve multiple HA±sialic acid interactions, is influenced by the abundance of receptors on the cell surface when the affinity of the HA for sialic acid is reduced.
DISCUSSION
Our analyses of the consequences for HA structure and receptor binding properties of the site-specific mutations we have introduced lead to three main conclusions. First, all except one mutant HA were expressed at the cell surface, reacted as native trimers with monoclonal antibodies of known specificity, and were specifically cleaved with trypsin into HA 1 and HA 2 to allow activation at low pH of their fusion potentials. We concluded, therefore, that all except one of the mutants were expressed as native, functional HAs. The exception, W153A, was expressed at a low level but was not detected at the cell surface. These observations are consistent with a structural role for this residue in the receptor binding site in addition to a direct role in receptor binding due to its proximity to the acetamido substituent of sialic acid (Sauter et al., 1989) . As a component of the hydrogen-bonded network of residues in the base of the site W153 interacts with Y195 and also forms part of an edge to face stack of aromatic residues with phenylalanines 147 and 148. The observation that mutant Y195F is able to bind to erythrocytes indicates that the hydrogen bond formed between W153 and Y195 is not essential for either receptor binding or for maintaining the structure of the site.
Second, on the basis of their abilities to bind erythrocytes the mutants can be divided into three groups:
(a) The mutant HAs Y98F, H183F, and L194A bound only weakly to erythrocytes; binding by L194A was consistently close to background. All three of these residues are conserved in influenza A HAs; in influenza B residue 98 is phenylalanine (Krystal et al., 1983) . Tyrosine 98 forms a hydrogen bond with histidine 183 and also appears to be the only residue in the site to interact with the 8-OH of sialic acid. Loss of either of these contacts may be responsible for the decrease in binding activity. The importance of the Y98±H183 interaction is also suggested by the negative binding phenotype of H183F. Although H183 forms a second hydrogen bond with the 9-OH substituent of sialic acid, E190 and S228 also interact with this substituent and may compensate for its loss in the H183F mutant. In addition the reported unchanged binding of 9-deoxysialic acid to HA suggests that none of the hydrogen bonds to the 9-OH plays a major role in receptor binding affinity (Kelm et al., 1992) . Together with W153 and L194, H183 is also involved in forming a hydrophobic surface with which the acetamido methyl group, C7, and C9 of sialic acid interact. The strict conservation of all three residues would be consistent with a major contribution of this surface to receptor binding and changes in the structure of the site as a result of the H183F substitution may indicate its importance.
(b) S136A, S136T, Y195F, G225D, and L226P demonstrate intermediate levels of erythrocyte binding. S136T, a natural variant in HAs of other subtypes, consistently bound to a greater extent than S136A, supporting the role of the conserved OH±amino acid in this position in forming a hydrogen bond with the carboxylate at position 1 of sialic acid. The peptide bond 137 amide proton also interacts with the carboxylate and this may explain the only partial abrogation of binding by the S136A mutation. Tyrosine 195 is a component of the hydrogen-bonded network of conserved residues that forms the base of the binding site and therefore plays a role in positioning these residues for their contacts with sialic acid, a role which appears to be at least partially fulfilled in the Y195F mutant. G225D is a natural variant in influenza H1 subtype HAs, although glycine 225 is conserved in all other influenza A HAs. This residue does not contact sialic acid but is part of a hydrophobic surface at the lower left edge of the receptor binding site. The glycine to aspartic acid substitution may influence the shape of this surface and the positions of residues 136 and 137 which contribute to it and are also responsible for interactions with the carboxylate of sialic acid.
The mutation L226P was previously reported to be one of two substitutions, together with S193N, in a monoclonal antibody-selected antigenic variant of X-31 (Daniels et al., 1987) . The selected variant was observed to display only transient hemagglutination and this is consistent with the decreased binding to erythrocytes that we recorded. Uniquely of the mutants analyzed here this HA fused cellular membranes to form polykaryons at higher pH than wild-type HA, pH 5.8 rather than pH 5.4, probably due to an effect of the mutation on the stability of the HA 1 ±HA 1 interface (Daniels et al., 1985 (Daniels et al., , 1987 . It is pos- sible that a structural change in the receptor binding site which this observation implies is responsible for the reduced ability of this mutant to bind erythrocytes. (c) The mutants E190A, G225R, and S228G appeared to bind to erythrocytes slightly more efficiently than wildtype HA. As noted above, substitutions at residue 225 may influence the positions on the lower edge of the site, of residues 136 and 137 that hydrogen bond with the sialic acid carboxylate. The increased binding by G225R may be a consequence of a similar but opposite effect of this mutation. Residue 190 is a conserved charged residue in the majority of HAs of all subtypes sequenced. It is in a position on the membrane distal edge of the site to hydrogen bond with the 9-OH of sialic acid, but in agreement with previous reports that HA has an unchanged affinity for 9-deoxysialic acid, the E190±9-OH interactions appear not to be essential for binding to human erythrocytes. Residue 228 is serine or glycine in all influenza A HAs. In X-31 HA S228 like E190 forms a hydrogen bond with the 9-OH of sialic acid. It is therefore not unexpected that the mutants S228G and E190A have similar binding phenotypes and, again, this is consistent with the unchanged binding of 9-deoxysialic acid (Kelm et al., 1992) .
Third, our estimates of changes in binding specificity were based on the inhibition of HA binding to erythrocytes by nonimmune horse sera which are known to be rich sources of sialic acids in ␣-2,6 linkage. For H3 subtype HAs results obtained with this assay have been observed to correlate with estimates of binding specificity derived from the use of cells derivatized with specific sialyltransferases (Rogers et al., 1983) . The extent of binding to erythrocytes of the three mutants Y98F, H183F, and L194A was too low to determine accurately the inhibition of binding by horse serum. Of the other mutants the specificities of Y195F and G225D were indistinguishable from that of wild type but G225R and L226P were clearly different, suggesting that they may preferentially recognize sialic acid in ␣2,3 linkage. This conclusion is in agreement with previous observations of the importance of residue 226 in influencing receptor binding specificity and with the effect of the L226P mutation on specificity estimated using both horse sera inhibition of hemagglutination by mutant virus and assays of virus binding to specifically derivatized erythrocytes (Daniels et al., 1987) . Erythrocyte binding by the four remaining mutant HAs, S136A, S136T, E190A, and S228G, was inhibited to intermediate levels between these two extremes of sensitivity and, again, mutant viruses with similar characteristics have been observed before (Rogers et al., 1983) . The molecular basis of the differences observed in receptor recognition specificity observed now for numerous mutant HAs has not been extensively explored. From structural studies of the L226Q mutant it appears that the left edge of the site containing Q226 closes toward S136 on the lower edge so that Q226 and S136 form a hydrogen bond. The position of Y98 is also changed to fill the space occupied in wild-type HA by the lower methyl group of leucine 226 and this change is accompanied by the movement en bloc of the hydrogen bonded residues 183, 195, and 153, with retention of their interresidue spacings (Weis et al., 1988) . Such small changes in the structure of the site are presumed to result in specificity differences even though none of the atoms of the 2,3 or 2,6 linkages contacts directly the different amino acid side chains of residue 226. The mutations in the same region studied here, L226P and G225R, cause the clearest differences in binding specificity and may result in similar structural rearrangements.
Equilibrium binding studies of wild-type X-31 and mutant HAs to the ␣-methylglycoside of sialic acid by NMR spectroscopy indicate a dissociation constant of 2.8 mM and experiments with a variety of ␣-linked sialoside receptor analogues have given similar values (Sauter et al., 1989 (Sauter et al., , 1992 . Attachment of viruses to cells at the beginning of infection is, therefore, assumed to involve a number of HA±receptor interactions that cooperatively bind a virus particle to the cell surface. Our experiments with viruses constructed by reverse genetics to contain specific receptor mutant HAs support this assumption. They indicate that even viruses containing HAs with one of the lowest affinities for erythrocyte receptors, Y98F, was capable of infecting eggs and MDCK cells to produce yields of infectious virus similar to that of wild-type X-31.
Further supportive evidence for the involvement of several HAs in effective cell association is provided by our experiments in which MDCK variant cells with less abundant cell surface sialic acid were not susceptible to infection by the weak binding mutant Y98F. These results emphasize the importance of cell surface sialic acid for influenza virus infection and also point to a balance that appears to exist between effective HA affinity, multiple HA±cell surface interactions, and infectivity. However, it seems that given a sufficient cell surface density of sialic acids, irrespective of linkage recognition specificity, influenza viruses will be capable of infecting cells.
MATERIALS AND METHODS
Mutagenesis, HA expression, and reverse genetics
The site-specific HA receptor mutations were generated either by the method of Kunkel et al. (1987) or by polymerase chain reaction (PCR) with mutant primers. The system developed by Blasco and Moss (1995) was used to make recombinant vaccinia viruses for HA expression. The vaccinia virus vRB 12 and expression vector pRB 21 used in this system were kindly provided by Dr. Bernard Moss. These viruses were generated and propagated in CV1 cells grown in Dulbecco's modified Eagle's medium supplemented with 5% fetal calf serum. Transfectant influenza viruses were generated essen-tially as described by Enami and Palese (1991) using  WSN virus (A/WSN/33, H 1 N 1 ) as helper virus and the reverse genetics vector pT3 X-31. This plasmid contains the cDNA of the HA gene of A/Aichi/2/68 (H 3 N 2 ) virus with a bacteriophage T3 promoter and a BsaI site positioned such that linearization of the vector followed by in vitro transcription yields vRNA sense transcripts of the HA gene with exact 3Ј and 5Ј noncoding terminal sequences. The infection/transfection step was done in MDBK cells and transfectant viruses were selected for growth in MDCK cells in the presence of anti-WSN rabbit serum.
Surface expression and membrane fusion assays
Assays for HA cell surface expression by trypsin cleavability were done using recombinant vaccinia virusexpressed HA on CV1 cells as described previously (Steinhauer et al., 1995) . Antibody reactivity was analyzed on recombinant vaccinia virus-infected HA-expressing HeLa cells by ELISA (Steinhauer et al., 1991b ) using a panel of monoclonal antibodies to different structural regions of the HA and a protein A-HRP conjugate. The pH of membrane fusion was assayed by polykaryon formation as detailed previously (Steinhauer et al., 1991a) . Briefly, BHK-21 cells were infected with recombinant vaccinia viruses and at 15 h postinfection cells were washed, trypsin-treated (5 g/ml, 5 min, 37°C) to cleave HA 0 into HA 1 and HA 2 , pH was adjusted for 1 min, then neutralized, and cells were incubated in complete medium for approximately 30 min. Cells were then fixed with 0.25% glutaraldehyde, stained with 1% toluidene blue, and photographed.
Receptor binding
Receptor binding activity was assayed by binding of red blood cells loaded with horseradish peroxidase (HRP) to HA-expressing HeLa cell monolayers. Human erythrocytes were loaded with HRP by the osmotic preswelling method (Rechsteiner, 1982) and un-entrapped HRP was removed by extensive washing. Recombinant vaccinia virus-infected HA-expressing cells in 24-well plates were treated with C. perfringens neuraminidase, a procedure required to maximize the HA binding potential (Ohuchi et al., 1995) and cells were trypsin-treated to cleave HA 0 into HA 1 and HA 2 . HRP-loaded erythrocytes (1% hematocrit) were then added and allowed to bind for 40 min at 37°C. Unbound red blood cells were removed by extensive washing and cell monolayers were fixed with 0.25% glutaraldehyde. The binding was quantified by assaying for HRP using 3,3Ј,5,5Ј-tetramethylbenzidene as substrate. The level of HA expression was assessed by ELISA in identical wells using anti-HA rabbit polyclonal serum and protein A±HRP conjugate and results were corrected for level of HA expression. As negative controls we used vaccinia-infected cells not expressing HA or erythrocytes which had been treated with neuraminidase to remove receptors for HA. In the horse serum inhibition assays, cells were incubated for 5 min prior to the addition of erythrocytes and serum and erythrocytes were co-incubated with cells as described above.
